NEWS AND HIGHLIGHTS
Latest from Tinos
IN FOCUS
NEWS
Apr 17, 2026
Servier’s Golden Ticket goes to Tinos Therapeutics to unlock the potential of epitranscriptomics in next-generation medicines
All
Press releases
News
News
NEWS
Apr 17, 2026
Servier’s Golden Ticket goes to Tinos Therapeutics to unlock the potential of epitranscriptomics in next-generation medicines
Press release
PRESS RELEASE
Sep 9, 2026
Tinos Therapeutics selected to present at Boston Biotech Investor Day (BBID) 2026